Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.88 -0.08 (-3.83%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Other financing activities (2020 - 2026)

Cardiol Therapeutics' (CRDL) quarterly Other financing activities came in at -$901571.7 in Q1 2026, down 1512.28% on a QoQ basis from $63838.1 in Q2 2024.

Cardiol Therapeutics (CRDL) Other financing activities (2020 - 2026) Analysis & Trends

Cardiol Therapeutics (CRDL) has 4 years of Other financing activities data on file, last reported at -$901571.7 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to -$901571.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$837733.6 (changed N/A YoY) and the FY2021 annual result came in at $2.3 million, up 1551.11% from the prior year.
  • Other financing activities eased to -$901571.7 in Q1 2026, from $63838.1 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $66936.4 in Q1 2024 to a low of -$901571.7 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Cardiol Therapeutics 215.50 Mn 196.65 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -901,571.69
Mar 31, 2026 -901,571.69
Jun 30, 2024 63,838.07
Jun 30, 2024 63,838.07
Mar 31, 2024 66,936.39
Mar 31, 2024 66,936.39
Sep 30, 2021 102,346.93
Sep 30, 2021 102,346.93
Jun 30, 2021 84,281.41
Jun 30, 2021 84,281.41
Mar 31, 2021 2.06 Mn
Mar 31, 2021 2.06 Mn
Dec 31, 2020 72,086.26
Dec 31, 2020 72,086.26